• 1
    McWilliams LA, Goodwin RD, Cox BJ. Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 2004; 111: 7783.
  • 2
    Leo RJ. Chronic pain and comorbid depression. Curr. Treat. Options Neurol. 2005; 7: 403412.
  • 3
    Arnow BA, Hunkeler EM, Blasey CM et al. Comorbid depression, chronic pain, and disability in primary care. Psychosom. Med. 2006; 68: 262268.
  • 4
    Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry, 9th edn. Lippincott Williams & Wilkins, Philadelphia, PA, 2003; 655658.
  • 5
    Marbach JJ, Hulbrook J, Hohn C, Segal AG. Incidence of phantom tooth pain: an atypical facial neuralgia. Oral Surg. Oral Med. Oral Pathol. 1982; 53: 190193.
  • 6
    Ikawa M, Yamada K, Ikeuchi S. Efficacy of amitriptyline for treatment of somatoform pain disorder in the orofacial region: a case series. J. Orofac. Pain 2006; 20: 234240.
  • 7
    Okubo Y, Suhara T, Suzuki K et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634636.
  • 8
    Suhara T, Okubo Y, Yasuno F et al. Decreased dopamine D2 receptor binding in the anterior cingulated cortex in schizophrenia. Arch. Gen. Psychiatry 2002; 59: 2530.
  • 9
    Arakawa R, Ito H, Takano A et al. Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia. Psychopharmacology 2008; 197: 229235.
  • 10
    Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur. J. Pain 2005; 9: 463484.
  • 11
    Carey P, Seedat S, Warwick J, van Heerden B, Stein DJ. SPECT imaging of body dysmorphic disorder. J. Neuropsychiatry Clin. Neurosci. 2004; 16: 357359.
  • 12
    Sundström T, Guez M, Hildingsson C, Toolanen G, Nyberg L, Riklund K. Altered cerebral blood flow in chronic neck pain patients but not in whiplash patients: a 99mTc-HMPAO rCBF study. Eur. Spine J. 2006; 15: 11891195.
  • 13
    Usui C, Doi N, Nishioka M et al. Electroconvulsive therapy improves severe pain associated with fibromyalgia. Pain 2006; 121: 276280.
  • 14
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). American Psychiatric Association, Washington, DC, 2000; 498503.
  • 15
    World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization, Geneva, 1992.
  • 16
    Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J. Nucl. Med. 1995; 36: 12381248.
  • 17
    Ringler R, Greiner M, Kohlloeffel L, Handwerker HO, Forster C. BOLD effects in different areas of the cerebral cortex during painful mechanical stimulation. Pain 2003; 105: 445453.
  • 18
    Ferretti A, Del Gratta C, Babiloni C et al. Functional topography of the secondary somatosensory cortex for nonpainful and painful stimulation of median and tibial nerve: an fMRI study. Neuroimage 2004; 23: 12171225.
  • 19
    Maihofner C, Forster C, Birklein F, Neundorfer B, Handwerker HO. Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study. Pain 2005; 114: 93103.
  • 20
    Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 2003; 126: 10791091.
  • 21
    Gündel H, Valet M, Sorg C et al. Altered cerebral response to noxious heat stimulation in patients with somatoform pain disorder. Pain 2008; 137: 413421.
  • 22
    Stoeter P, Bauermann T, Nickel R et al. Cerebral activation in patients with somatoform pain disorder exposed to pain and stress: an fMRI study. Neuroimage 2007; 36: 418430.
  • 23
    Honda T, Maruta T, Takahashi K. Brain perfusion abnormality in patients with chronic pain. Keio J. Med. 2007; 56: 4852.
  • 24
    Derbyshire SWG, Jones AKP, Devani P et al. Cerebral responses to pain in patients with atypical facial pain measured by positron emission tomography. J. Neurol. Neurosurg. Psychiatry 1994; 57: 11661172.
  • 25
    Thunberg J, Lyskov E, Korotkov A et al. Brain processing of tonic muscle pain induced by infusion of hypertonic saline. Eur. J. Pain 2005; 9: 185194.
  • 26
    Inoue K, Nakagawa M, Goto R et al. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Eur. J. Nucl. Med. Mol. Imaging 2003; 30: 14891497.
  • 27
    Kohn Y, Freedman N, Lester H et al. 99mTc-HMPAO SPECT study of cerebral perfusion after treatment with medication and electroconvulsive therapy in major depression. J. Nucl. Med. 2007; 48: 12731278.
  • 28
    Pharo GH, Zhou L. Controlling cancer pain with pharmacotherapy. J. Am. Osteopath. Assoc. 2007; 107: 2232.
  • 29
    Clark GT, Ram S. Orofacial pain and neurosensory disorders and dysfunction in cancer patients. Dent. Clin. North Am. 2008; 52: 183202.
  • 30
    McGeeney BE. Adjuvant agents in cancer pain. Clin. J. Pain 2008; 24: 1420.
  • 31
    Singh VP, Jain NK, Kulkarni SK. On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res. 2001; 915: 218226.
  • 32
    Duman EN, Kesim M, Kadioglu M, Yaris E, Kalyoncu NI, Erciyes N. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. J. Pharmacol. Sci. 2004; 94: 161165.
  • 33
    Kesim M, Duman EN, Kadioglu M, Yaris E, Kalyoncu NI, Erciyes N. The different roles of 5-HT(2) and 5-HT(3) receptors on antinociceptive effect of paroxetine in chemical stimuli in mice. J. Pharmacol. Sci. 2005; 97: 6166.